Surgiphor Us in TSA
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Rothman Institute Orthopaedics
- Study ID
- NCT06601803
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Povidone Iodine
- Shoulder Infection
- Total Shoulder Arthroplasty
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- sterile saline solution — DRUGThe shoulder will be washed with normal sterile saline before and after placing the shoulder implant
- Surgiphor — DRUGThe shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant
- Sample Collection — PROCEDUREDuring the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure
Study Details
Bacteria is occasionally present in the shoulder during shoulder arthroplasty surgery and is hypothesized to increase the risk of failure of the prosthesis. Surgiphor (sterile Povidone-Iodine) wound irrigation, is a solution used in orthopaedic surgery and other surgical fields to kill bacteria intraoperatively. The Iodine dissociates from complex and has antimicrobial properties, causing cell death of bacteria, fungi, and viruses through interactions with proteins, nucleotides, and fatty acids in the cytoplasm and cytoplasmic membrane. This study examines the use of Povidone-Iodine during primary shoulder arthroplasty.
Key Dates
- Start date
- Sep 16, 2024
- Status verified
- Sep 2024
- Primary completion
- Sep 30, 2025
- Completion
- Sep 30, 2025
Study Design
- Enrollment
- 126 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Total Shoulder Arthroplasty washed with SalineThis arm will consist of sterile normal saline to be used before and after placement of shoulder arthroplasty components
- Active Comparator: Total Shoulder Arthroplasty washed with Surgiphor (Povidone Iodine)This arm will consist of Surgiphor to be used before and after placement of shoulder arthroplasty components
Primary Outcome Measure
Reduction or elimination of bacteria [ Time Frame: 90 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rothman Orthopaedic Institute | Philadelphia | Pennsylvania | 19107 | - |
Find similar trials in Philadelphia, PA
By research site
Related Studies
- Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid ConsumptionEnrolling By Invitation · The Cooper Health System · Camden, New Jersey
- Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder ReplacementPHASE4 · Recruiting · University of Minnesota · Minneapolis, Minnesota
- ZYNRELEF vs Continuous Catheter for Pain Management Following Shoulder ArthroplastyPHASE4 · Enrolling By Invitation · Washington University School of Medicine · St Louis, Missouri
- Subscapularis-Sparing Total Shoulder ArthroplastyEnrolling By Invitation · University of Utah · Salt Lake City, Utah